Startups
Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery.
Over 300 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL, Jersey City, NJ. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.
Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.
Over 300 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL, Jersey City, NJ. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.
Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.
Overview
Location
United States, Florida, Kendall
Employees
501-1000
Founded date
1987
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 30, 2025 | Noven Pharmaceuticals and juli Partner to Enhance Whole-Patient Care in Mental Health | Noven Pharmaceuticals partners with juli to launch Mindful Patch™, an optional ADHD companion app enhancing medication adherence & patient well-being. Mindful Patch brings a new element to helping patients stay on course with ADHD treat... |
| Jul 11, 2007 | Noven Pharma to acquire JDS Pharma for $125M | Noven Pharmaceuticals, a Miami developer of drug-patch technologies and products, agreed to acquire privately held JDS Pharmaceuticals of New York for $125 million. JDS specializes in neurological drugs, including its antidepressant Pexeva ... |
Reviews 0
FAQ about Noven Pharmaceuticals
When was Noven Pharmaceuticals founded?
Noven Pharmaceuticals was founded in 1987.
What has the press written about Noven Pharmaceuticals?
Parsers VC has collected 3 articles mentioning Noven Pharmaceuticals, among them “Noven Pharmaceuticals and juli Partner to Enhance Whole-Patient Care in Mental Health” (Jan 30, 2025) and “Noven Pharma to acquire JDS Pharma for $125M” (Jul 11, 2007).
Is Noven Pharmaceuticals still active?
Yes, Noven Pharmaceuticals is active; its latest activity on Parsers VC dates from Jun 26, 2026.